Free Trial

Celcuity (CELC) Competitors

Celcuity logo
$13.16 +0.40 (+3.13%)
Closing price 04:00 PM Eastern
Extended Trading
$13.16 +0.00 (+0.04%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CELC vs. NHC, VRDN, AGL, FTRE, CDNA, AHCO, GRAL, AVAH, PNTG, and CSTL

Should you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include National HealthCare (NHC), Viridian Therapeutics (VRDN), agilon health (AGL), Fortrea (FTRE), CareDx (CDNA), AdaptHealth (AHCO), Grail (GRAL), Aveanna Healthcare (AVAH), The Pennant Group (PNTG), and Castle Biosciences (CSTL). These companies are all part of the "healthcare" industry.

Celcuity vs.

National HealthCare (NYSE:NHC) and Celcuity (NASDAQ:CELC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, community ranking, risk and earnings.

National HealthCare has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500.

In the previous week, National HealthCare had 3 more articles in the media than Celcuity. MarketBeat recorded 4 mentions for National HealthCare and 1 mentions for Celcuity. Celcuity's average media sentiment score of 0.68 beat National HealthCare's score of 0.17 indicating that Celcuity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National HealthCare
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Celcuity
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

56.4% of National HealthCare shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 13.8% of National HealthCare shares are held by company insiders. Comparatively, 15.8% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

National HealthCare has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National HealthCare$1.14B1.37$66.80M$7.9812.71
CelcuityN/AN/A-$63.78M-$2.61-4.97

National HealthCare has a net margin of 10.03% compared to Celcuity's net margin of 0.00%. National HealthCare's return on equity of 6.87% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
National HealthCare10.03% 6.87% 4.68%
Celcuity N/A -62.66%-39.78%

Celcuity has a consensus target price of $30.17, indicating a potential upside of 132.61%. Given Celcuity's stronger consensus rating and higher possible upside, analysts clearly believe Celcuity is more favorable than National HealthCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National HealthCare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Celcuity
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14

Celcuity received 336 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 67.60% of users gave Celcuity an outperform vote.

CompanyUnderperformOutperform
National HealthCareOutperform Votes
2
100.00%
Underperform Votes
No Votes
CelcuityOutperform Votes
338
67.60%
Underperform Votes
162
32.40%

Summary

National HealthCare and Celcuity tied by winning 9 of the 18 factors compared between the two stocks.

Get Celcuity News Delivered to You Automatically

Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CELC vs. The Competition

MetricCelcuityMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$480.83M$3.23B$5.82B$9.18B
Dividend YieldN/A19.55%5.25%3.99%
P/E Ratio-4.9615.9824.8119.27
Price / SalesN/A173.19465.4979.23
Price / CashN/A378.2844.6537.93
Price / Book2.375.257.635.18
Net Income-$63.78M-$22.21M$3.19B$245.95M
7 Day Performance4.50%3.50%1.18%1.70%
1 Month Performance18.66%8.39%3.21%1.19%
1 Year Performance-14.90%17.40%20.06%15.79%

Celcuity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CELC
Celcuity
2.1109 of 5 stars
$13.16
+3.1%
$30.17
+129.2%
-16.3%$488.63MN/A-5.0440Short Interest ↑
NHC
National HealthCare
N/A$100.71
+1.0%
N/AN/A$1.55B$1.14B12.6213,123Dividend Announcement
News Coverage
VRDN
Viridian Therapeutics
2.9499 of 5 stars
$17.98
+1.2%
$35.70
+98.6%
-14.7%$1.42B$310,000.00-4.1750News Coverage
AGL
agilon health
1.5939 of 5 stars
$3.29
-1.4%
$4.03
+22.6%
-51.5%$1.35B$4.32B-3.491,117Upcoming Earnings
News Coverage
FTRE
Fortrea
2.3792 of 5 stars
$15.07
+1.1%
$23.30
+54.6%
-57.3%$1.35B$3.11B-4.4118,000
CDNA
CareDx
3.0711 of 5 stars
$24.91
+11.2%
$28.33
+13.7%
+201.2%$1.34B$312.78M-9.23740Upcoming Earnings
Analyst Downgrade
High Trading Volume
AHCO
AdaptHealth
3.4564 of 5 stars
$9.16
-1.8%
$12.40
+35.4%
+16.5%$1.23B$3.20B-5.5510,700
GRAL
Grail
1.0579 of 5 stars
$33.37
+3.6%
$16.00
-52.1%
N/A$1.12BN/A0.001,360Short Interest ↓
AVAH
Aveanna Healthcare
0.683 of 5 stars
$4.76
+1.9%
$4.51
-5.2%
+107.9%$919.78M$1.90B-14.0033,500News Coverage
PNTG
The Pennant Group
3.7717 of 5 stars
$26.68
+0.3%
$36.00
+34.9%
+65.4%$916.46M$544.89M39.245,791Upcoming Earnings
Positive News
CSTL
Castle Biosciences
2.071 of 5 stars
$27.71
+0.4%
$40.29
+45.4%
+5.6%$776.16M$219.79M138.56540

Related Companies and Tools


This page (NASDAQ:CELC) was last updated on 2/19/2025 by MarketBeat.com Staff
From Our Partners